Mesotherapy for Hair Loss
Discover a revolutionary solution to hair loss. Our advanced injectables are designed to stimulate hair growth and restore your natural look.
Ready to Get Started?
Fill out our provider enrollment form and a member of our team will reach out to discuss next steps and answer any questions.
Clinical Data
Mesotherapy is a non-surgical treatment option involving micro-injections of a solution with minoxidil and/or dutasteride directly into the scalp. Below are some of the studies surrounding mesotherapy for hair loss.
Mesotherapy with Dutasteride for Androgenetic Alopecia: A Retrospective Study in Real Clinical Practice
Intradermal injections with 0.5% minoxidil for the treatment of female androgenetic alopecia: A randomized, placebo-controlled trial
Mesotherapy with Dutasteride for Androgenetic Alopecia: A Retrospective Study in Real Clinical Practice
SUMMARY
Mesotherapy with Dutasteride for Androgenetic Alopecia: Retrospective Study
Objective: To assess the safety and effectiveness of mesotherapy with dutasteride for androgenetic alopecia (AGA) in real clinical practice.
Method: Retrospective study on 541 AGA patients receiving mesotherapy with dutasteride. Data on treatment response and side effects were analyzed.
Results: Mesotherapy with dutasteride was effective in improving hair loss in both men and women. Pain was the most common side effect, but generally mild and self-limiting. No serious adverse events were reported.
Conclusion: Mesotherapy with dutasteride is a safe and effective option for AGA treatment, especially for patients wishing to avoid oral medications. Treatment every three months showed promising results.
View the Full Study
SUMMARY
Intradermal injections with 0.5% minoxidil for the treatment of female androgenetic alopecia: A randomized, placebo-controlled trial
This study investigated the effectiveness and safety of intradermal injections of 0.5% minoxidil for treating female androgenetic alopecia (FAGA). A randomized, placebo-controlled trial involving 54 women diagnosed with FAGA compared the treatment group receiving minoxidil injections to a placebo group. Evaluation methods included biopsy, trichogram, Trichoscan analysis, and self-assessment.
Results showed a significant improvement in hair density, an increase in the percentage of anagen hairs, and a better self-reported reduction in hair loss and volume in the minoxidil group compared to placebo. The study concluded that intradermal minoxidil injections were more effective than placebo with a good safety profile, suggesting a potential alternative therapy for FAGA.
View the Full Study
SUMMARY
This study compared dutasteride intralesional microinjections (DIM) plus oral minoxidil (OM) versus OM alone in men with androgenetic alopecia (AGA). They conducted a retrospective study on 105 male AGA patients who declined oral 5-alpha-reductase inhibitors. DIM involved monthly dutasteride injections mixed with saline into the alopecic area for three months. Results showed both groups had improvement, with the OM plus DIM group showing better outcomes in the vertex area. No sexual dysfunction was reported. The study suggests DIM with OM could be an effective and safe alternative for AGA in men.